MedPath

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.

Phase 3
Completed
Conditions
Colorectal Neoplasms
Colonic Neoplasms
Rectal Neoplasms
Interventions
Registration Number
NCT00056459
Lead Sponsor
Novartis
Brief Summary

To compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread to other organs and are seeking first chemotherapy treatment

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1168
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2VatalanibOxaliplatin/5-FU/LV and placebo
1VatalanibOxaliplatin/5-FU/LV and PTK787/ZK 222584
Primary Outcome Measures
NameTimeMethod
Progression free survivalThroughout duration of study
Secondary Outcome Measures
NameTimeMethod
Time to progressionThroughout duration of study
Time to treatment failureThroughout duration of study
Tolerability and safety profileThroughout duration of study
Best overall response rateThroughout duration of study

Trial Locations

Locations (144)

Alabama Hematology/Oncology

🇺🇸

Birmingham, Alabama, United States

Palo Verde Hematology & Oncology

🇺🇸

Glendale, Arizona, United States

Arizona Cancer Center

🇺🇸

Tucson, Arizona, United States

Northeast Arkansas Clinic

🇺🇸

Jonesboro, Arkansas, United States

Highlands Oncology Group

🇺🇸

Springdale, Arkansas, United States

Comprehensive Blood and Cancer Center

🇺🇸

Bakersfield, California, United States

Providence St. Joseph Medical Center

🇺🇸

Burbank, California, United States

Compassionate Cancer Care Medical Group, Inc

🇺🇸

Fountain Valley, California, United States

California Oncology of the Central Valley

🇺🇸

Fresno, California, United States

Virginia K. Crosson Cancer Center

🇺🇸

Fullerton, California, United States

Scroll for more (134 remaining)
Alabama Hematology/Oncology
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.